Screening and identification of the ncRNA-mRNA regulatory network associated with DNA methylation in goose embryonic myoblasts Authors: Yongquan Luo, Pufei Hong, Tiande Chen, Yong Li, Yuanhao Han, Kaiyue Chang, Ziyang Liu, Xiujin Li, Yunmao Huang, Yunbo Tian, Zhongping Wu, Xumeng Zhang Published: 2026 ABSTRACT BackgroundLocal goose breeds Shitou and Wuzong exhibit distinct growth rates, implying divergent embryonic muscle development. This study used embryonic myoblasts from the Magang goose, an established model with superior growth traits, to explore the underlying common regulatory mechanisms. Extending our previous findings that 5-AZA (DNA methylation inhibitor) and BC339 (DNA hydroxylation inhibitor) oppositely affect myoblast proliferation and differentiation, we performed whole-transcriptome sequencing on inhibitor-treated goose embryonic myoblasts. This aimed to identify DNA methylation-mediated ncRNA-mRNA networks governing myoblast fate, with key interactions being functionally validated.Result5-AZA significantly promotes cell proliferation and differentiation by inhibiting DNA methyltransferase activity and reducing DNA methylation levels, whereas BC339 significantly suppresses cell proliferation and differentiation by inhibiting demethylation and increasing DNA methylation levels. Specifically, we identified 6,309 mRNAs, 579 lncRNAs, 194 miRNAs, and 825 circRNAs that were differentially expressed in response to 5-AZA and BC339 treatment. Based on GO and KEGG enrichment analyses, differentially expressed genes related to muscle development were selected to construct a ceRNA network. This network comprises 5 differentially expressed lncRNAs (DELs: MSTRG.17572.1, XR_001211738.1, MSTRG.1886.1, XR_001212555.1, MSTRG.8995.2), 2 differentially expressed circRNAs (DECs: novel_circ_029953, novel_circ_017636), 11 differentially expressed miRNAs (DEMs: miR-383-x, miR-10174-y, miR-191-x, miR-24-x, miR-9619-y, novel-m0303-5p, novel-m0105-3p, miR-204-x, miR-211-z, novel-m0075, miR-26-y), 5 differentially expressed genes (DEGs: KIF3A, CCND1, PPM1A, Table 2, TGFBR1), forming a total of 24 interactions.This study identified miR-9619-y as a critical negative regulator of goose embryonic myoblast development through targeted inhibition of CCND1. Dual-luciferase reporter assays confirmed the direct binding of miR-9619-y to the 3’-untranslated region of CCND1. Functional experiments demonstrated that overexpression of miR-9619-y significantly reduced the EdU-positive cell ratio and myotube area percentage, accompanied by cell cycle arrest at the G0/G1 phase. Conversely, inhibition of miR-9619-y promoted myoblast proliferation and differentiation while decreasing the proportion of cells in G0/G1 phase. During the proliferation stage, miR-9619-y overexpression significantly suppressed CCND1 expression at both mRNA and protein levels, down-regulated MyoD expression, and reduced Myf5 mRNA abundance; whereas miR-9619-y inhibition up-regulated these genes and their corresponding proteins. During the differentiation stage, overexpression of miR-9619-y similarly decreased the mRNA levels of CCND1, Myh1, and MyoG, as well as the protein levels of MyHC and CCND1, with inhibition producing the opposite effects.ConclusionIn this study, we predicted a ceRNA network based on bioinformatics analysis governing goose embryonic myoblast development, identifying key molecular components including mRNAs, miRNAs, lncRNAs, and circRNAs, along with 24 regulatory axes. Functional experiments further demonstrated that miR-9619-y arrests cell cycle progression and negatively regulates the proliferation and differentiation of goose embryonic myoblasts, as evidenced by its impact on both the mRNA and protein expression of key myogenic factors through targeted inhibition of CCND1. These findings, together with the bioinformatically predicted ceRNA network, suggest potential complex post-transcriptional regulatory mechanisms underlying myogenesis in geese and offer candidate molecular targets for genetic improvement of meat production performance in waterfowl breeding programs.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12864-026-13044-8. Introduction Meat goose farming holds significant importance in China’s poultry industry due to its high economic efficiency. Goose meat contains up to 22.3% protein and is rich in essential amino acids and unsaturated fatty acids, providing notable health benefits. Regarding growth performance, Shitou geese and Wuzong geese exhibit pronounced differences. As a large meat-type breed, Shitou geese achieve body weights of 7.5 kg in males by 90 days, with a feed-to-gain ratio of 1.7:13. Conversely, Wuzong geese grow slower, reaching only 3.2 kg by 100 days. However, they possess superior intramuscular fat content (IMF) and finer myofiber diameter, conferring tender texture and richer flavor compounds [1]. These contrasting traits underpin complementary roles in modern production systems: Shitou geese meet demand for large-scale processing, while Wuzong geese dominate the premium roasted goose market. The synergy between Shitou geese and Wuzong geese drives industrial upgrading through differentiated breeding objectives [2]. However, the mechanisms underlying these phenotypic disparities remain unclear, although they are presumably linked to differential muscle growth and development. Embryonic muscle development is a critical phase determining meat production potential in geese, during which Shitou geese and Wuzong geese exhibit significant divergence. Our previous study demonstrated that at embryonic day 23 (E23), myofibers in Shitou geese were clearly distinguishable in the leg muscle of Shitou geese, whereas those in Wuzong geese remained largely undifferentiated. Additionally, the cross-sectional area of myofiber bundles was significantly larger in Shitou geese compared to Wuzong geese [3]. This accelerated growth correlated with reduced Myostatin (MSTN) expression after E23, synergistically driving rapid myoblast proliferation. Conversely, Wuzong geese initially show higher myofiber density in pectoralis early development (E10), though this advantage diminishes progressively during later embryogenesis [4]. Regarding temporal patterning of pectoralis differentiation, Shitou geese exhibit delayed pectoralis myofiber maturation (completing only at hatching), whereas Wuzong geese initiate pectoralis differentiation earlier but maintain lower total myofiber counts throughout embryogenesis [5]. Embryonic myogenesis is hierarchically orchestrated by the sequential activation of key transcription factors – Paired box 7 (Pax7), Myoblast Determination Protein 1 (MyoD), and Myogenin (MyoG) – which initiate myogenic commitment. This process is further defined by the integration of extrinsic signaling pathways, including WNT, NOTCH, and BMP/TGF-β, transmitted via non-cell-autonomous hormonal signals and cell-intrinsic cascades, thereby ensuring spatiotemporal precision during myoblast proliferation, differentiation, and fusion [6–8]. Beyond genetic regulation, epigenetic mechanisms also play crucial roles. Research showed DNA methylation mediated by DNA methyltransferases (DNMTs) depositing 5-methylcytosine (5mC), dynamically regulates gene expression as a key epigenetic modification [9]. Our previous research has shown that embryonic leg muscle in Wuzong geese (WZE) exhibited accelerated global CG hypomethylation during embryonic day 23 (E23) to post-hatch day 1 (P1), where earlier demethylation near transcription start sites (TSS) of myogenic genes (e.g., MyoD) correlated with their premature expression; whereas Shitou geese (STE) displayed more intense myofiber development at E23 despite higher overall methylation levels and slower demethylation dynamics [10]. In addition, Non-coding RNAs (ncRNAs) similarly function as epigenetic regulators. Both circ_0001012 and MSTRG.21919.1 are enriched in the PPAR/mTOR signaling pathway, promoting lipid synthesis by up-regulating fatty acid synthase (FASN) and peroxisome proliferator-activated receptor γ (PPARγ) expression [1, 11, 12]. What’s more, DNA methylation affects the proliferation and differentiation of Shitou geese myoblasts by regulating differentially spliced genes in the Wnt-related signaling pathway and the lncRNA-mRNA interaction network [13]. As mentioned previously, despite having higher overall methylation levels and slower dynamics of demethylation, the Shitou geese exhibited superior muscle fiber development. This suggests that the epigenetic regulation of muscle development is highly locus-specific. Nevertheless, the regulatory mechanisms linking ncRNAs to DNA methylation in geese remain unclear. Two inhibitors were used to manipulate DNA methylation and demethylation. Specifically, 5-azacytidine (5-AZA) inhibits DNMTs to promote myoblast demethylation and differentiation [14], while BC339 inhibits TETs to suppress MSTN expression, without affecting DNMT activity [15]. Our previous study demonstrated the significant impact of 24-h treatment with 5-AZA (DNA methylation inhibitor) and BC339 (DNA hydroxylation inhibitor) on myoblast proliferation and differentiation. Treatment with 5-AZA significantly enhanced cellular proliferation and differentiation, while the effect is the opposite after treatment with BC339 [16]. However, these findings represent a superficial outcome and the underlying mechanisms by which BC339/5-AZA influence the regulatory network of key genes to affect muscle proliferation and differentiation remain unclear and warrant further investigation. This study conducted whole-transcriptome sequencing of goose embryonic myoblasts-under proliferating and differentiating conditions-subjected to BC339, 5-AZA, or untreated controls. This approach aims to identify DNA methylation-associated ncRNA-mRNA regulatory networks governing myoblast proliferation/differentiation, followed by functional validation of key networks. Consequently, this study established a systematic understanding of the mechanisms underlying divergent embryonic skeletal muscle development in goose breeds of varying body sizes and provide a theoretical foundation for developing molecular breeding markers in future research. Materials and methods Animal ethics All animal experiments were carried out in strict accordance with the guidelines of the China Council on Animal Care. The study protocol was specifically reviewed and approved by the Animal Experiment Committee of Zhongkai University of Agriculture and Engineering (Approval No. 2021112709). The animals were bred and housed in a facility certified by the Animal Care and Use Committee of Guangdong Province, China (Facility License Nos. SCXK 2021−0019 and SYXK 2021-0080). The goose embryos and geese used in this study were commercially obtained. Specifically, 17-day-old Magang goose embryos were purchased from Guangdong Jinye Poultry Seedling Breeding Co., Ltd. One-day-old Shitou and Wuzong geese, as well as their corresponding embryos, were purchased from Qingyuan Baixian Agricultural Technology Co., Ltd. Prior informed consent for the use of these animals in research was obtained from the owners (the respective commercial suppliers). Experimental processing and grouping In this study, myoblasts were extracted from goose E17 embryos and treated with 50 mmol/L concentration BC339 (PBC), 25 µmol/L concentration 5-AZA (P5A), and the dimethyl sulfoxide vehicle control (PNC) at 24 h of the proliferation period for culture. During the 24 h differentiation period, the treatment was carried out using 50 mmol/L concentration BC339 (DBC), 25 µmol/L concentration 5-AZA (D5A), and the dimethyl sulfoxide vehicle control (DNC) before culture. There were a total of 6 treatment groups above, with 3 replicates in each group. Cells of different treatments were collected respectively for whole transcriptome sequencing and related molecular experiments. Based on the sequencing results, different treatment groups were compared, key regulatory differentially expressed genes were screened and identified, and the ncRNA-mRNA regulatory network was constructed through targeted prediction. Animals and tissue sampling The pectoral muscle, leg muscle, liver, heart, lung, spleen, kidney, brain and adipose tissues of 1-day-old Wuzong geese and Shitou geese were collected, as well as the pectoral and leg muscle tissues at the embryonic stage of 14 and 22 days. Additionally, the embryonic myoblasts of Magang geese were isolated and cultured until the proliferation and differentiation stages. Cell culturing At the beginning, goose embryos at embryonic day 17 (E17) were taken, thoroughly washed with benzalkonium bromide, placed in a super-clean workbench, and the blunt end of tweezers was used to strike the air cell end to peel off and remove the entire embryo, which was then placed in a petri dish containing PBS. Then, the leg muscle tissue was cut with ophthalmic scissors and placed in PBS solution. The surrounding bone, skin, fascia, and blood vessels were carefully excised with forceps. Following this, the isolated tissue was transferred to a 1.5 mL centrifuge tube and homogenized using ophthalmic scissors. After that, it was ground to a paste with a grinding rod and finally transferred to a 50 mL centrifuge tube. Then, 0.25% trypsin (5–10 times the tissue volume) was added, the mixture was blown into a suspension, and digested in a 37 °C water bath for 5–10 min. Digestion was terminated by adding an equal volume of DMEM/F-12 medium containing 20% FBS and 1% double antibiotic. The digested cell suspension was then passed through a 200-mesh cell sieve; afterwards, the suspension was centrifuged at 4 °C and 1000 r/min for 5 min, the supernatant was discarded, and the pellet was re-suspended in an appropriate amount of DMEM/F-12 medium containing 20% FBS and 1% double antibiotic, pipetted evenly, and adjusted to a cell density of 4 × 105 cells/mL; finally, the cell suspension was inoculated into 10 cm culture dishes and cultured in a 37℃, 5% CO2 incubator for 1.5–2 h. The supernatant was then aseptically transferred to a new culture plate for subsequent culture [17–19]. EdU experiment EdU labeling was performed as follows: first, prepare a 50 µM EdU medium at a ratio of Reagent A to complete cell culture medium of 1:1000 in an appropriate volume. Cells were incubated with 100 µL of EdU medium per well for 2 h. Following medium removal, cells were washed 1–2 times with PBS (5 min per wash). For fixation, 50 µL of cell fixative (4% paraformaldehyde in PBS) was added to each well and incubated at room temperature for 30 min. After discarding the fixative, 50 µL of 2 mg/mL glycine was added per well and incubated on a shaker for 5 min, followed by removal of the glycine solution. Cells were then washed with 100 µL PBS on a decolorization shaker for 5 min. Subsequently, cells were permeabilized with 100 µL of penetrant (0.5% Triton X-100 in PBS) on a shaker for 10 min, followed by a final 5-min PBS wash. For Apollo staining, 100 µL of 1x Apollo staining reaction solution was added to each well (prepared in a 1 mL system: 938 µL deionized water, 50 µL reagent B, 10 µL reagent C, 3 µL reagent D, 9 mg reagent E). The plate was incubated at room temperature in the dark on a shaker for 30 min, after which the staining reaction solution was discarded. Cells were washed with 100 µL of penetrant on a shaker 2–3 times, 10 min each time, and the penetrant was discarded. A final wash was performed with PBS for 5 min. To prepare the DNA stain, a 1× Hoechst 33,342 working solution was made by diluting reagent F 100-fold in deionized water and kept away from light. Then, 100 µL of the solution was added per well and the plate was incubated in the dark on a shaker for 30 min at room temperature. Following incubation, the staining solution was removed and wells were washed 1–3 times with 100 µL PBS. After the final wash, 100 µL PBS was added to each well to preserve the samples. Imaging was performed using an inverted fluorescence microscope, and the EdU positive rate of cells was statistically analyzed using ImageJ 6.0 [20, 21]. Immunofluorescence experiment The cells were first fixed and washed by discarding the culture medium, followed by washing with 100 µL PBS for 2–3 times. Subsequently, Following fixation in 4% paraformaldehyde (10 min, room temperature, with shaking) and three 5-min PBS washes, cells were permeabilized using 0.5% Triton X-100 for 10 min at room temperature, followed by three additional PBS washes. Blocking was performed with 5% bovine serum albumin (BSA) solution for 1 h at room temperature, after which the blocking solution was removed. We performed immunostaining for myosin heavy chain (MYHC) using a specific primary antibody (4 °C, overnight) followed by a secondary antibody (room temperature, 1 h, in the dark), with three PBS washes conducted after each antibody step. Nuclear staining was performed using DAPI staining solution for 5 min at room temperature in the dark, followed by three final PBS washes. Images were acquired using an inverted fluorescence microscope, and quantitative analysis of MYHC-positive rate and myotube diameter was performed using ImageJ 6.0 software. The entire protocol strictly adhered to reagent volumes (100 µL per well), precise timing (to the minute), and temperature control (4 °C/room temperature) for the rigorous and replicable generation of data. Extraction of total RNA The culture medium was discarded from the culture plate, and each well was washed twice with PBS. After discarding the PBS, 1 mL of Trizol was added to each well. After lysing for 10 min, the mixture was pipetted to homogenize it before transferring to a 1.5 mL nuclease-free centrifuge tube. Then, 200 µL of chloroform was added to each tube, vortexed for 30 s, and left at room temperature for 2 min. Then, the tubes were centrifuged at 4℃ and 12,000 rpm for 15 min. After centrifugation, the RNA was present in the upper colorless aqueous phase. The supernatant was transferred to a new 1.5 mL nuclease-free centrifuge tube, and an equal volume of isopropanol was added. After vortexing for 30 s, the tubes were left at room temperature for 10 min and then centrifuged at 4℃and 12,000 rpm for 10 min. The RNA precipitate was located on the side or bottom of the tube. The supernatant was discarded, and 1 mL of 75% ethanol (pre-chilled, prepared with DEPC water and anhydrous ethanol) was added. The tubes were centrifuged at 4℃ and 7500 rpm for 5 min, and the supernatant was discarded. This washing step was repeated once. After discarding the supernatant, the tube was inverted on a clean paper towel for 3–5 min. Then, 20 µL of DEPC water was added, and the tube was vortexed for 1 min and centrifuged in a mini-centrifuge for 20 s. The OD value was measured with a spectrophotometer, and the RNA was considered usable if the OD value was between 1.8 and 2.0. The extracted RNA was stored at −80℃. Whole transcriptome sequencing data analysis method mRNA and lncRNA sequencing data analysis Following total RNA extraction, rRNA was depleted to maximize the retention of both coding and non-coding RNAs. The resulting rRNA-depleted RNA was fragmented into short segments. Using these fragmented RNAs as templates, first-strand cDNA was synthesized with random hexamers. Second-strand cDNA was then synthesized by adding buffer, dNTPs (with dUTP substituted for dTTP), RNase H, and DNA polymerase I. The double-stranded cDNA was purified using the QiaQuick PCR Purification Kit and eluted with EB buffer. The purified DNA underwent end repair, ‘A’-tailing, and adapter ligation. The second strand, containing dUTP, was subsequently degraded using Uracil-N-Glycosylase (UNG) to generate strand-specific libraries. The libraries were size-selected by agarose gel electrophoresis and amplified by PCR. The final qualified libraries were sequenced on an Illumina HiSeq™ 4000 platform (Illumina, San Diego, CA, USA) to generate 150-bp paired-end reads. Following library preparation and sequencing, based on established bioinformatics workflows, raw sequencing reads underwent quality control using fastpto remove adapter-contaminated sequences, reads with > 10% N bases, poly-A homopolymers, and low-quality reads (Q ≤ 20 bases constituting ≥ 50% of the read), generating clean reads (Table S1). These reads were aligned to the reference genome using HISAT2, followed by transcript assembly and quantification via StringTieto reconstruct both known and novel transcripts (Chen et al., 2018). Differential expression analysis of mRNAs was performed using DESeq2 (v3.14.0) in R, applying a negative binomial generalized linear model, with statistically significant differentially expressed genes (DEGs) filtered using thresholds of |log₂FC| > 2 and adjusted p-value < 0.05. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for the DEGs were conducted using the R package clusterProfiler (v3.14.3) for functional annotation. Novel transcripts were assessed for coding potential using Coding Potential Calculator and Coding-Non-Coding Index to identify novel lncRNAs. Expression levels of mRNAs and lncRNAs were quantified across samples, followed by lncRNA-mRNA co-expression analysis to identify regulatory relationships. MicroRNA sequencing data analysis Raw sequencing data underwent preprocessing by removing 5’ adapters while retaining sequences upstream of 3’ adapters, filtering low-quality reads (containing N bases or > 1 bases with Q < 20), reads without inserts or with inserts < 18 nt, and reads with ≥ 70% consecutive A bases to generate high-quality clean reads. Clean reads were then processed to derive small RNA tags, which were annotated against reference genomes and databases (e.g., miRBase) to identify small RNA composition and miRNAs, yielding miRNA expression profiles. miRNA identification was performed using miRDeep2 (v2.0.1) against the miRBase (v22) database. Differentially expressed microRNAs (DEMs) were identified with DESeq2 (v1.34.0) using thresholds of |log₂FC| > 2 and adjusted p-value < 0.05. miRNA target prediction was conducted using miRanda (v3.3a) with a scoring threshold of ≥ 140 and an energy threshold of ≤ −17 kcal/mol, and cross-validated using TargetScan (v7.0). Functional annotation of the predicted targets, including GO enrichment and KEGG pathway analysis, was then performed with the clusterProfiler R package (v3.14.3). Circular RNA sequencing data analysis High-quality (HQ) clean reads were obtained by filtering the raw sequencing data to trim adapter sequences, discard low-quality bases (Q < 20), and remove contaminant sequences. Alignment of the HQ clean reads to the reference genome was performed with HISAT2 (v2.2.1), using default parameters except for --no-mixed and --no-discordant. CIRI2 (v2.0.6) was used to identify circRNAs based on back-splicing junction reads. Subsequent analyses include: (1) characterization of circRNA types (e.g., exonic or intronic), chromosomal distribution, and junction read counts; (2) quantification of circRNA expression levels using metrics such as junction reads per million (RPM) and differential expression analysis between groups with with DESeq2 (v1.34.0) using thresholds of |log₂FC|> 2 and adjusted p-value < 0.05; (3) functional annotation against circBase or circBank databases. miRNA target prediction for circRNAs was performed using miRanda (v3.3a) with a score cutoff of ≥ 140, and experimentally validated interactions were retrieved from miRTarBase (v8.0). Construction of the ceRNA network To construct the ceRNA network, a systematic filtering strategy integrating differential expression and correlation analysis was applied. First, significantly differentially expressed RNAs (DEGs, DELs, DECs, and DEMs) were identified. For mRNAs, lncRNAs, and circRNAs, the criteria were set as FDR < 0.05 and |log2 Fold Change (log2FC)| > 2. For miRNAs, the threshold was P < 0.05 and |log2FC| > 2. Subsequently, candidate ceRNA interactions were filtered based on the following three criteria: miRNA-Target Negative Correlation: The expression correlation between miRNAs and their putative target ceRNAs (mRNAs, lncRNAs, or circRNAs) was calculated using Spearman’s rank correlation coefficient. Only pairs exhibiting a significant negative correlation (correlation coefficient ≤ −0.7) were retained to conform to the ceRNA regulatory mechanism. ceRNA Positive Correlation: According to the ceRNA hypothesis, ceRNAs competing for the same miRNA are expected to exhibit positively correlated expression. Therefore, Pearson’s correlation coefficient was calculated for candidate ceRNA pairs. Pairs with a correlation coefficient ≥ 0.9 were identified as potential competing pairs. Enrichment Analysis: To further validate the reliability of the identified ceRNA pairs, hypergeometric cumulative distribution function tests were performed. Only pairs with a P-value < 0.05 were finally included in the ceRNA network. The final network visualization was constructed using Cytoscape software. RNA reverse transcription and real-time fluorescence quantitative PCR detection After subjecting RNA to heat denaturation at 65℃ for 5 min followed by immediate placement on ice, the following reactions were prepared (in a 10 µL system, with all operations conducted on ice): The RT reaction was assembled to 8 µL (2 µL 4×DN Master Mix, 0.5 µg RNA, Nuclease-free Water), mixed, and incubated at 37 °C for 5 min. Following addition of 2 µL 5× RT Master Mix II and further mixing, cDNA was synthesized in a PCR cycler (37 °C, 15 min; 50 °C, 5 min; 98 °C, 5 min) and stored at −20 °C. RT-qPCR reactions (10 µL) with GAPDH reference and 5 µL SYBR Green Master Mix were prepared in a 384-well plate.,0.25 µL each of upstream and downstream primers, 0.5 µL of cDNA, and 4 µL of RNase-free ddH₂O. The PCR plate was placed in QuantStudio™ Real-Time PCR instrument with the reaction program set as follows: the thermal cycling conditions were: 95 °C for 5 min; then 35 cycles of 95 °C for 15 s, 60 °C for 15 s, and 72 °C for 15 s. Melting curve analysis was set as follows: 95 °C for 15 s, 60 °C for 1 min, 95 °C for 15 s, and 60 °C for 15 s. Post-run data were analyzed via the 2^(–ΔΔCt) method to determine relative gene expression. Table S2 showed the primer sequences synthesized by Sangon Biotech based on the sequencing result sequences. Cell transfection Based on the GenBank sequence of miR-9619-y, corresponding mimics, inhibitors, and negative controls were synthesized by RIBOBIO Biology for functional studies in goose embryonic myoblasts. Transfections were carried out using 5 µL of Lipofectamine 3000 reagent with 50 nM of either miR-9619-y mimics or mimics NC. In the proliferation assay, cells at 60% confluence were transfected, incubated in growth medium for 24 h after a 6-h transfection period, and then sampled. For differentiation analysis, transfection was initiated at 80% confluence; following 6 h, the medium was changed to differentiation medium, and samples were taken after 48 h. Extraction of cellular proteins and western blotting experiment The culture medium was discarded from the culture plate, cells were washed twice with PBS, and 200 µL of 1×sample buffer cell lysis solution (RIPA lysis buffer: after adding lysis buffer (RIPA: PMSF: proteinase inhibitor: EDTA = 100:1:1:1) and incubating on ice for 10 min, cells were scraped, transferred to a 1.5 mL tube, and homogenized. The lysate was then centrifuged (12,000 rpm, 4 °C, 5 min); the resulting supernatant was transferred to a fresh tube, combined with 1× loading buffer, denatured in a metal bath for 10 min, and stored at −80 °C. Protein concentration was measured using a BCA kit for subsequent SDS-PAGE. The resolving gel was prepared by mixing 2.7 mL each of resolving gel solutions A and B and 60 µL of accelerator, and the stacking gel by mixing 0.75 mL each of stacking gel solutions A and B and 15 µL of accelerator. Once the gel had set (15–20 min, room temperature), protein samples were loaded and electrophoresed at 80 V for 15–20 min; the voltage was then increased to 110 V and maintained for 60–70 min. After electrophoresis, the gel was transferred to transfer buffer, and the transfer assembly was constructed with a PVDF membrane (activated in methanol) between filter papers, placed between the electrodes. Transfer was performed at 200 A, with time adjusted based on protein size. Following blocking in 5% skim milk/PBST (1–2 h, room temperature), the membrane was incubated with primary antibody at 4 °C overnight. After three PBST washes, it was treated with secondary antibody (1 h, room temperature) followed by a final series of three PBST washes. Finally, the membrane was immersed in ECL developer solution (1:1 mixture of A and B) for 1–2 min, exposed and imaged using a chemiluminescent imaging system. Protein bands were quantified using ImageJ 6.0 software. Dual-luciferase reporter assay PCR primers were designed based on the target fragment, and both wild-type and mutant fragments containing the designed mutation (see Table S3 for target gene sequences) were obtained by PCR amplification. The amplified wild-type and mutant fragments were purified and recovered, then inserted into the dual‑luciferase reporter vector pmiR‑RB‑Report™ via homologous recombination, yielding the wild-type and mutant recombinant plasmids, respectively. Following transformation into E. coliTOP10 competent cells, the mixture was plated on ampicillin plates and incubated at 37 °C for 16 h. Single colonies were then picked for colony PCR screening. Positive clones identified by PCR were further confirmed by Sanger sequencing to verify the correct inserted sequence. The successfully constructed clones were then cultured in liquid medium for strain preservation and subsequent plasmid extraction. The pmiR‑RB‑REPORT™ dual‑luciferase reporter vector uses Renillaluciferase (hRluc) as the primary reporter and firefly luciferase (hluc) as an internal control for normalization. A reporter construct was generated in which the 3′UTR sequence was placed downstream of the hRluccoding region. Since miRNAs typically act on target genes through their 3′UTR, co‑transfection of the miRNA and the constructed reporter vector allows the detection of miRNA–target interaction via a decrease in the normalized luciferase activity (hRluc/hluc ratio). At 37 °C and 5% CO₂, 293 T cells were cultured under standard conditions. For the assay, cells in the logarithmic growth phase were seeded into 96-well plates at a density of 1.0 × 10⁴ cells per well in 100 µL medium and cultured for 24 h. Prior to transfection, a mixture was prepared by diluting miRNA mimics or Non-target Control. Transfection complexes were prepared by separately diluting 50 ng of plasmid (wild-type or mutant 3′UTR reporter) and 50 nM miRNA mimics with P3000 reagent in 5 µL Opti-MEM, and Lipofectamine™ 3000 in another 5 µL Opti-MEM, combining them, and incubating for 15 min at room temperature. Cells in 96-well plates were pre-conditioned with 90 µL fresh medium per well before adding 10 µL of complex (final volume 100 µL; n = 3). After 6 h, medium was replaced. For detection, assay substrates were prepared according to manufacturer’s instructions and stored at −80 °C until use. At 48 h post-transfection, cells were lysed in 35 µL PBS, followed by sequential addition of 35 µL luciferase reagent (incubate 10 min, read luminescence) and 30 µL Stop reagent (incubate 10 min, read fluorescence) in a white 96-well plate. Flow cytometry Goose embryonic myoblasts were collected 24 h after transfection, resuspended at a density of 1 × 106 cells, and centrifuged at 3000 rpm for 5 min at 4℃. The pellet was washed with ice-cold PBS and fixed with 1 mL of ice-cold 70% ethanol at 4℃ for at least 30 min. After fixation, cells were washed twice with PBS and incubated with 100 µg/mL RNase A at 37 °C for 30 min to degrade RNA. Subsequently, cells were stained with 50 µg/mL propidium iodide (PI) in the dark at 4 °C for 30 min. For cell cycle analysis, data were acquired using a BD FACSCanto™ II flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star, Inc.). The gating strategy involved excluding debris and aggregates based on forward and side scatter (FSC/SSC) profiles and PI-Area vs. PI-Width plots. It is important to note that, due to the technical limitation of distinguishing quiescent (G0) from actively cycling G1 cells using DNA content alone (without Ki-67 or BrdU co-staining), the results are presented as the combined G0/G1 fraction. Data statistics and analysis Data were processed in Microsoft Excel 2019, with statistical analyses (correlation, one-way ANOVA) performed in IBM SPSS Statistics 26.0 and GraphPad Prism 6.0; the latter was also used for graphing. Figures were prepared using Adobe Photoshop and Illustrator 2020. Results are presented as mean ± SD. Significant differences (P < 0.05) were determined by one-way ANOVA with post-hoc tests and are indicated by distinct letter superscripts. P < 0.05 and P < 0.01 were considered statistically and highly significant, respectively. Results The influence of DNA methylation on goose embryonic myoblasts To investigate the effects of the DNA methyltransferase inhibitor 5-AZA on DNA methylation levels and the proliferation and differentiation of goose embryonic myoblasts, this study established a model with reduced DNA methylation using 5-AZA. Treatment with 5-AZA for 24 h significantly decreased DNA methylation levels during both the proliferation and differentiation phases compared to the NC group (P < 0.01) (Figure S1), confirming successful model establishment. EdU staining revealed significantly higher EdU-positive rates in the treated group during the proliferation phase and significantly higher myotube fusion rates during the differentiation phase compared to controls (P < 0.01) (Figure S2), indicating that 5-AZA significantly promotes proliferation and differentiation by inhibiting DNA methyltransferase activity and lowering DNA methylation. Furthermore, a model with elevated DNA methylation was established using the DNA demethylase inhibitor BC339. BC339 treatment for 24 h significantly increased 5mC levels during proliferation and differentiation compared to the NC group (P < 0.01) (Figure S3), confirming model establishment. EdU staining showed significantly lower positive rates in the treated group during proliferation and significantly lower myotube fusion rates during differentiation than controls (P < 0.01) (Figure S4), demonstrating that BC339 significantly inhibits proliferation and differentiation by suppressing demethylation and increasing DNA methylation levels. Analysis of DEGs in the proliferation and differentiation phases By integrating the transcriptomic data, we identified 6,309 DEGs across all comparisons, including those within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC) (Fig. 1A, Table S4), among which the log2FC and FDR values of mRNA are shown in the volcano plot in the Figure. Of these, comparison between PNC and P5A yielded 5,550 DEGs, including 3,794 up-regulated (68.36%) and 1,756 down-regulated (31.64%); a total of 5034 DEGs were identified in the leg muscles of the PNC and PBC comparison groups, including 3,322 up-regulated (65.99%) and 1,712 down-regulated (34.01%); a total of 2,095 DEGs were identified in the leg muscles of the P5A and PBC comparison groups, including 910 up-regulated (43.43%) and 1185 down-regulated (56.57%); a total of 3,727 DEGs were identified in the leg muscles of the DNC and D5A comparison groups, including 1,212 up-regulated (32.52%) and 2, 515 down-regulated (67.48%); a total of 2,185 DEGs were identified in the leg muscles of the DNC and DBC comparison groups, including 296 up-regulated (13.54%) and 1,889 down-regulated (86.46%); a total of 2,435 DEGs were identified in the leg muscles of the DNC and DBC comparison groups, including 1, 076 up-regulated (44.19%) and 1,359 down-regulated (55.81%) (Fig. 1B). To visually display the expression patterns of transcriptional changes, a heatmap was used to show the expression of selected differentially expressed genes across groups. The heatmap clearly demonstrates that the expression patterns of these key differentially expressed genes were able to effectively distinguish the treatment groups (5-AZA, BC339) from their respective control groups (PNC, DNC) and from each other, further confirming the substantial transcriptional impact produced by these two epigenetic modulators (Fig. 1C). Fig. 1DEGs identify and analysis. A Venn diagram displaying the mRNA number. The diagram displays the overlap of significantly differentially expressed mRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DEGs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DEGs. The bar graph presents the number of significantly up-regulated and down-regulated DEGs for each of the six treatment comparisons mentioned in (A). C Heatmap of DEGs. The heatmap visualizes the standardized expression levels (Z-score) of DEGs across biological replicate samples from the six experimental groups. D GO classification of DEGs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment DEGs identify and analysis. A Venn diagram displaying the mRNA number. The diagram displays the overlap of significantly differentially expressed mRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DEGs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DEGs. The bar graph presents the number of significantly up-regulated and down-regulated DEGs for each of the six treatment comparisons mentioned in (A). C Heatmap of DEGs. The heatmap visualizes the standardized expression levels (Z-score) of DEGs across biological replicate samples from the six experimental groups. D GO classification of DEGs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment To investigate the functions of the differentially expressed genes (DEGs), GO and KEGG enrichment analyses were conducted. The majority of DEGs were annotated into key GO terms across three categories: for Biological Process (BP), these included “metabolic process”, “single-organism process”, and “cellular process”; for Cellular Component (CC), terms such as “cell part”, “cell”, and “membrane” were enriched; and for Molecular Function (MF), significant terms were “binding”, “transporter activity”, and “catalytic activity” (Fig. 1D, Table S5). The KEGG pathway enrichment results for DEGs are illustrated in Fig. 1E and Table S6, which only includes the top 10 pathways. Significantly enriched pathways included myocardial contraction, regulation of the actin cytoskeleton, and the MAPK signaling pathway. Analysis of differentially expressed lncRNAs (DELs) in the proliferation and differentiation phases Whole-transcriptome analysis further identified 579 DELs from six comparative groups spanning the proliferation and differentiation phases (Fig. 2 A, Table S7), among which the log2FC and FDR values of lncRNA are shown in the volcano plot in the Figure. Among these genes, a total of 544 DELs were identified in the leg muscles of the PNC and P5A comparison groups, including 262 up-regulated (48.16%) and 282 down-regulated (51.84%); a total of 390 DELs were identified in the leg muscles of the PNC and PBC comparison groups, including 182 up-regulated (46.67%) and 208 down-regulated (53.33%); a total of 292 DELs were identified in the leg muscles of the P5A and PBC comparison groups, including 124 up-regulated (42.46%) and 168 down-regulated (57.54%); a total of 533 DELs were identified in the leg muscles of the DNC and D5A comparison groups, including 216 up-regulated (40.52%) and 317 down-regulated (59.48%); a total of 204 DELs were identified in the leg muscles of the DNC and DBC comparison groups, including 48 up-regulated (23.53%) and 156 down-regulated (76.47%); a total of 331 DELs were identified in the leg muscles of the D5A and DBC comparison groups, including 156 up-regulated (47.13%) and 175 down-regulated (52.87%) (Fig. 2B). To visually display the expression patterns of transcriptional changes, a heatmap was used to show the expression of selected differentially expressed genes across groups. The heatmap clearly demonstrates that the expression patterns of these key differentially expressed genes were able to effectively distinguish the treatment groups (5-AZA, BC339) from their respective control groups (PNC, DNC) and from each other, further confirming the substantial transcriptional impact produced by these two epigenetic modulators (Fig. 2C). Fig. 2DELs identify and analysis. A Venn diagram displaying the lncRNA number. The diagram displays the overlap of significantly differentially expressed lncRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DELs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DELs. The bar graph presents the number of significantly up-regulated and down-regulated DELs for each of the six treatment comparisons mentioned in (A). C Heatmap of DELs. The heatmap visualizes the standardized expression levels (Z-score) of DELs across biological replicate samples from the six experimental groups. D GO classification of DELs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment DELs identify and analysis. A Venn diagram displaying the lncRNA number. The diagram displays the overlap of significantly differentially expressed lncRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DELs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DELs. The bar graph presents the number of significantly up-regulated and down-regulated DELs for each of the six treatment comparisons mentioned in (A). C Heatmap of DELs. The heatmap visualizes the standardized expression levels (Z-score) of DELs across biological replicate samples from the six experimental groups. D GO classification of DELs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment GO and KEGG analyses of DELs revealed their functional associations. Key enriched GO terms spanned BP (“metabolic process”, “single-organism process”, “cellular process”), CC (“cell part”, “cell”, “membrane”), and MF (“binding”, “transporter activity”, “catalytic activity”) (Fig. 2D). KEGG analysis of the top 10 enriched pathways showed a strong focus on vascular smooth muscle contraction, glutathione metabolism, and apoptosis (Fig. 2E). Analysis of DEMs in the proliferation and differentiation phases Based on the whole transcriptome data, we identified a total of 194 DEMs from six comparative groups spanning the proliferation and differentiation phases (Fig. 3A, Table S8), among which the log2FC and FDR values of miRNA are shown in the volcano plot in the Figure. Among these genes, a total of 165 DEMs were identified in the leg muscles of the PNC and P5A comparison groups, including 44 up-regulated (26.67%) and 121 down-regulated (73.3%); a total of 135 DEMs were identified in the leg muscles of the PNC and PBC comparison groups, including 29 up-regulated (21.48%) and 106 down-regulated (78.52%); a total of 42 DEMs were identified in the leg muscles of the P5A and PBC comparison groups, including 21 up-regulated (50.00%) and 21 down-regulated (50.00%); a total of 123 DEMs were identified in the leg muscles of the DNC and D5A comparison groups, including 73 up-regulated (59.35%) and 50 down-regulated (40.65%); a total of 87 DEMs were identified in the leg muscles of the DNC and DBC comparison groups, including 49 up-regulated (56.32%) and 38 down-regulated (43.68%); a total of 69 DEMs were identified in the leg muscles of the D5A and DBC comparison groups, including 37 up-regulated (53.62%) and 32 down-regulated (46.38%) (Fig. 3B). To visually display the expression patterns of transcriptional changes, a heatmap was used to show the expression of selected differentially expressed genes across groups. The heatmap clearly demonstrates that the expression patterns of these key differentially expressed genes were able to effectively distinguish the treatment groups (5-AZA, BC339) from their respective control groups (PNC, DNC) and from each other, further confirming the substantial transcriptional impact produced by these two epigenetic modulators (Fig. 3C). Fig. 3DEMs identify and analysis. A Venn diagram displaying the miRNA number. The diagram displays the overlap of significantly differentially expressed miRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DEMs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DEMs. The bar graph presents the number of significantly up-regulated and down-regulated DEMs for each of the six treatment comparisons mentioned in (A). C Heatmap of DEMs. The heatmap visualizes the standardized expression levels (Z-score) of DEMs across biological replicate samples from the six experimental groups. D GO classification of DEMs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment DEMs identify and analysis. A Venn diagram displaying the miRNA number. The diagram displays the overlap of significantly differentially expressed miRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DEMs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DEMs. The bar graph presents the number of significantly up-regulated and down-regulated DEMs for each of the six treatment comparisons mentioned in (A). C Heatmap of DEMs. The heatmap visualizes the standardized expression levels (Z-score) of DEMs across biological replicate samples from the six experimental groups. D GO classification of DEMs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment GO and KEGG analyses of DEMs revealed their functional enrichment. Key GO terms included BP (“cellular process”, “biological regulation”, “metabolic process”), CC (“cell”, “cell part”, “membrane”), and MF (“binding”, “catalytic activity”, “transporter activity”) (Fig. 3D). The top 10 KEGG pathways were significantly enriched, particularly in endocytosis, glutathione metabolism, and adherens junction (Fig. 3E). Analysis of differentially expressed circRNAs (DECs) in the proliferation and differentiation phases Based on the whole transcriptome data, we identified a total of 825 DECs from six comparative groups spanning the proliferation and differentiation phases (Fig. 4A, Table S9), among which the log2FC and FDR values of cirRNA are shown in the volcano plot in the Figure. Among these genes, a total of 815 DECs were identified in the leg muscles of the PNC and P5A comparison groups, including 396 up-regulated (48.59%) and 419 down-regulated (51.41%); a total of 800 DECs were identified in the leg muscles of the PNC and PBC comparison groups, including 371 up-regulated (46.37%) and 429 down-regulated (53.63%); a total of 434 DECs were identified in the leg muscles of the P5A and PBC comparison groups, including 216 up-regulated (49.78%) and 218 down-regulated (50.22%); a total of 459 DECs were identified in the leg muscles of the DNC and D5A comparison groups, including 221 up-regulated (48.15%) and 238 down-regulated (51.85%); a total of 370 DECs were identified in the leg muscle of the DNC and DBC comparison groups, including 196 up-regulated (52.97%) and 174 down-regulated (47.03%); a total of 381 DECs were identified in the leg muscles of the D5A and DBC comparison groups, including 208 up-regulated (54.59%) and 173 down-regulated (45.41%) (Fig. 4B). To visually display the expression patterns of transcriptional changes, a heatmap was used to show the expression of selected differentially expressed genes across groups. The heatmap clearly demonstrates that the expression patterns of these key differentially expressed genes were able to effectively distinguish the treatment groups (5-AZA, BC339) from their respective control groups (PNC, DNC) and from each other, further confirming the substantial transcriptional impact produced by these two epigenetic modulators (Fig. 4C). Fig. 4DECs identify and analysis. A Venn diagram displaying the circRNA number. The diagram displays the overlap of significantly differentially expressed circRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DECs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DECs. The bar graph presents the number of significantly up-regulated and down-regulated DECs for each of the six treatment comparisons mentioned in (A). C Heatmap of DECs. The heatmap visualizes the standardized expression levels (Z-score) of DECs across biological replicate samples from the six experimental groups. D GO classification of DECs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment DECs identify and analysis. A Venn diagram displaying the circRNA number. The diagram displays the overlap of significantly differentially expressed circRNAs identified from six pairwise comparisons within the proliferation phase (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and the differentiation phase (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC). The specific numbers within each segment of the Venn diagram represent the count of DECs unique to or shared between the indicated treatment comparisons. B Statistics on the number of down- and up-regulated DECs. The bar graph presents the number of significantly up-regulated and down-regulated DECs for each of the six treatment comparisons mentioned in (A). C Heatmap of DECs. The heatmap visualizes the standardized expression levels (Z-score) of DECs across biological replicate samples from the six experimental groups. D GO classification of DECs. The bar plot shows the significantly enriched GO terms within the three main categories: Biological Process (BP), Cellular Component (CC), and Molecular Function (MF). E A scatterplot representing the top 10 pathways based on KEGG enrichment Functional enrichment analyses (GO and KEGG) were conducted to explore the roles of the DECs. Functional annotation revealed that the majority of DECs were associated with key GO terms: BP (e.g., cellular process, biological regulation, metabolic process), CC (e.g., cell, cell part, membrane), and MF (e.g., binding, catalytic activity, transcription regulator activity) (Fig. 4D). Pathway enrichment analysis indicated that the DECs were significantly involved in several of the top 10 KEGG pathways, particularly the MAPK signaling pathway, Wnt signaling pathway, and adherens junction (Fig. 4E). Construction of lncRNA-miRNA-mRNA and circRNA-miRNA-mRNA ceRNA network To elucidate the regulatory mechanisms governing myoblast fate, we integrated transcriptomic profiles from both proliferation and differentiation stages. We aimed to identify stable regulatory axes potentially mediated by DNA methylation that persist across developmental transitions. We constructed a ceRNA network by intersecting DELs, DEGs, and DECs that shared common regulatory DEMs across both proliferation-stage comparisons (PNC vs. P5A, PNC vs. PBC, P5A vs. PBC) and differentiation-stage comparisons (DNC vs. D5A, DNC vs. DBC, D5A vs. DBC), we aimed to construct a comprehensive ceRNA network. This approach allows us to identify regulatory interactions that are either stage-specific or constitutively active under altered methylation states. By screening the DELs, DEGs, and DECs that are regulated by the same DEMs in the DEmiRNA-DElncRNA, DEmiRNA-DEGs, and DEmiRNA-DEcircRNA regulatory relationships, we in silico predicted 11 circRNA-miRNA-mRNA and 11 lncRNA-miRNA-mRNA interactions. The predicted ceRNA network includes 5 DELs (MSTRG.17572.1, XR_001211738.1, MSTRG.1886.1, XR_001212555.1, MSTRG.8995.2), 2 DECs (novel_circ_029953, novel_circ_017636), 11 DEMs (miR-383-x, miR-10174-y, miR-191-x, miR-24-x, miR-9619-y, novel-m0303-5p, novel-m0105-3p, miR-204-x, miR-211-z, novel-m0075, miR-26-y), 5 DEGs (KIF3A, CCND1, PPM1A, Table 2, TGFBR1), and 24 total interactions (Fig. 5, Figure S5). Fig. 5Predicted ceRNA network based on bioinformatics analysis Predicted ceRNA network based on bioinformatics analysis The expression profiles of cirRNA/lncRNA/miRNA/mRNA in different tissues of two goose breeds and during the proliferation and differentiation stages of goose embryonic myoblasts The expression levels of cirRNA/lncRNA/miRNA/mRNA in different tissues The RT-qPCR analysis revealed distinct tissue-specific expression patterns of various genes and non-coding RNAs between Shitou geese and Wuzong geese. Specifically, CCND1 expression was significantly up-regulated in the lung tissue of Shitou geese (P < 0.05), whereas it showed no significant differences across all examined tissues in Wuzong geese (P > 0.05). Similarly, KIF3A was significantly highly expressed in the brain of Shitou geese but exhibited no significant differential expression in other tissues of either breed. Regarding miRNA expression, miR-383-x was relatively highly expressed in the kidney, lung, and leg muscle tissues of both breeds. In contrast, miR-9619-y showed relatively high expression in the lung, kidney, spleen, brain, and leg muscle of Shitou geese, whereas in Wuzong geese, its expression was predominant in the liver, leg muscle, and adipose tissue. The lncRNA MSTRG.17572.1 was predominantly expressed in the lung, spleen, and adipose tissue of Shitou geese, but in Wuzong geese, it was more abundant in the lung, spleen, and brain. For the novel circRNAs, novel_circ_017636 was highly expressed in the lung, leg muscle, and pectoral muscle of Shitou geese, while in Wuzong geese, it was primarily detected in the pectoral muscle, leg muscle, and lung. Conversely, novel_circ_029953 was highly expressed in the lung, brain, kidney, and adipose tissue of Shitou geese, but in the lung, spleen, and heart of Wuzong geese. Notably, the expression of XR_01211738.1 was consistently and relatively high in the lung, spleen, and kidney tissues of both breeds. Given their high expression in muscle tissues, miR-9619-y and novel_circ_017636 represent promising candidates for future functional studies (Fig. 6A). RT-qPCR analysis revealed distinct tissue-specific expression patterns of key RNAs in 1-day-old geese. While these data provide insights into the basal expression profiles of these molecules in vivo, it is important to note that the regulatory environment of hatched geese differs substantially from that of embryonic development. The expression patterns observed at 1-day-old may not fully recapitulate the transcriptional landscape of embryonic myoblasts. Therefore, candidate prioritization based on these postnatal data should be interpreted with caution, and future studies involving embryonic tissues are warranted to validate these expression dynamics. Fig. 6Expression profiles and RT-qPCR validation of candidate RNAs in goose tissues and myoblasts. A Gene expression in different tissues of one-day-old Shitou geese and Wuzong geese. B The gene expression levels of the pectoral and leg muscles of Shitou geese and Wuzong geese in E14 and E22 of the embryonic period. C The comparison results of RT-qPCR detection and sequencing of gene expression levels. Data are means ± SEDs; Bars sharing the same letter or without any letter label indicate no statistically significant difference (P > 0.05), whereas those labeled with different letters denote statistically significant differences (P < 0.05) Expression profiles and RT-qPCR validation of candidate RNAs in goose tissues and myoblasts. A Gene expression in different tissues of one-day-old Shitou geese and Wuzong geese. B The gene expression levels of the pectoral and leg muscles of Shitou geese and Wuzong geese in E14 and E22 of the embryonic period. C The comparison results of RT-qPCR detection and sequencing of gene expression levels. Data are means ± SEDs; Bars sharing the same letter or without any letter label indicate no statistically significant difference (P > 0.05), whereas those labeled with different letters denote statistically significant differences (P < 0.05) Profiling of circRNA/lncRNA/miRNA/mRNA expression in pectoral and leg muscle of Shitou and Wuzong geese at E14 and E22 At embryonic day 14, CCND1 expression in pectoral muscle of Shitou geese was significantly higher than in Wuzong geese (P < 0.05), whereas CCND1 expression in leg muscle was significantly lower (P < 0.01). Concurrently, novel_circ_017636 expression in leg muscle was significantly elevated in Shitou geese (P < 0.05). Additionally, in Shitou geese pectoral muscle, the expression levels of KIF3A, miR-383-x, miR-9619-y, MSTRG.17572.1, XR_001211738.1, novel_circ_017636, and novel_circ_029953 showed no significant difference compared to those in Wuzong geese (P > 0.05). In leg muscle, the expression levels of KIF3A, miR-383-x, miR-9619-y, MSTRG.17572.1, XR_001211738.1 and novel_circ_029953 also exhibited no significant difference between Shitou and Wuzong geese (P > 0.05). At embryonic day 22, MSTRG.17572.1 expression in pectoral muscle of Shitou geese was significantly higher than in Wuzong geese (P < 0.05), while miR-383-x expression in leg and pectoral muscle showed a significant increase (P < 0.05). Besides, in pectoral muscle, the expression levels of CCND1, KIF3A, miR-9619-y, XR_001211738.1, novel_circ_017636 and novel_circ_029953 showed no significant difference between Shitou geese and Wuzong geese (P > 0.05). Similarly, in leg muscle, the expression levels of CCND1, KIF3A, miR-9619-y, MSTRG.17572.1, XR_001211738.1, novel_circ_017636 and novel_circ_029953 also exhibited no significant difference between the two breeds. In summary, at E14, both CCND1 and novel_circ_017636 showed higher expression in the muscle tissues of Shitou geese, while at E22, miR-383-x and MSTRG.17572.1 were more highly expressed. These genes therefore warrant further investigation (P > 0.05) (Fig. 6B). The expression levels of cirRNA/lncRNA/miRNA/mRNA in the proliferation and differentiation stages of goose embryonic myoblasts treated with 5-AZA and BC339 The comparative analysis between RT-qPCR validation and transcriptome sequencing data revealed generally consistent yet distinct patterns across different molecules and treatment groups. For protein-coding genes, the RT-qPCR results for CCND1 showed consistent trends with the sequencing data across all treatments except for the PBC group during the proliferation stage, while complete consistency was observed during the differentiation stage. Similarly, KIF3A expression exhibited consistency in all proliferation-stage treatments except PBC; however, during differentiation, consistency was maintained except for the D5A group. Regarding miRNAs, miR-383-x demonstrated fully concordant trends between the two methods during proliferation but diverged during differentiation. Conversely, miR-9619-y showed agreement in all proliferation-stage treatments except PNC, yet inconsistency emerged in the differentiation phase. For non-coding RNAs, the lncRNA MSTRG.17572.1 displayed consistent trends except for the PBC group during proliferation but became inconsistent during differentiation, whereas XR_01211738.1 remained consistent in all proliferation treatments except PBC and showed full concordance in differentiation. Notably, both novel_circ_017636 and novel_circ_029953 exhibited incomplete consistency between RT-qPCR and sequencing data across both proliferation and differentiation stages. In summary, the expression levels of CCND1, miR-383-x, MSTRG.17572.1, and XR_01211738.1 during the cell proliferation phase show a high concordance with the sequencing results (r > 0.5011). Therefore, these genes warrant further investigation in the context of goose embryonic myoblast development (Fig. 6C). MiR-9619-y inhibited the proliferation and differentiation of goose embryonic myoblasts From the constructed ceRNA network, the miR-9619-y/CCND1 axis was prioritized for functional validation due to its central role in cell cycle regulation and its distinct expression pattern in vivo. As detailed in Section "Profiling of circRNA/lncRNA/miRNA/mRNA expression in pectoral and leg muscle of Shitou and Wuzong geese at E14 and E22", CCND1 exhibited significantly higher expression in the muscle tissues of Shitou geese (the breed with superior muscle development) compared to Wuzong geese at E14. Furthermore, CCND1 is a well-established master regulator of the G1/S transition, making it the most biologically relevant target to mechanistically explain the proliferation and differentiation phenotypes induced by 5-AZA and BC339. Computer modeling analysis using RNAhybrid indicated that the 3’UTR of CCND1 contains a putative binding site with high affinity for the seed sequence of miR-9619-y (Fig. 7A). To directly test the targeting of miR-9619-y on CCND1, we constructed a pmiR-RB-REPORT™ dual-luciferase reporter vector containing a segment of the CCND1 3’UTR with either the predicted miR-9619-y binding site (wild-type; CCND1-WT) or a mutated version of this site (CCND1-MUT) (Fig. 7B). Compared to the negative control (NC), co-transfection with Acy-miR-9619-y mimics resulted in a significant increase in reporter fluorescence from the Acy-CCND1-MUT vector relative to the Acy-CCND1-WT vector. Therefore, the miR-9619-y mimics can regulate CCND1 expression through this specific site (Fig. 7C). To verify whether miR-9619-y mimics or miR-9619-y inhibitors was successfully transfected, RT-qPCR was performed. Transfection with miR-9619-y mimics led to a marked increase in its expression level relative to the mimics NC group. Conversely, introduction of the miR-9619-y inhibitors resulted in a significant knockdown compared to its corresponding NC group (Fig. 7D). In line with this, EdU incorporation assays showed that miR-9619-y overexpression substantially reduced the percentage of EdU-positive cells, indicating an inhibition of cell proliferation (Fig. 7E-H). Consistently, MyHC immunofluorescence confirmed that miR-9619-y overexpression led to a marked reduction in myogenic differentiation (Fig. 7I-L). To further investigate the effects of miR-9619-y on goose embryonic myoblast development, flow cytometry was employed to analyze cell cycle progression. The results revealed that transfection with miR-9619-y mimics significantly increased the proportion of goose embryonic myoblasts in G0/G1 and G2/M phases, while markedly decreasing the proportion of cells in S phase (P < 0.05) (Fig. 7M, N). Conversely, transfection with miR-9619-y inhibitors significantly reduced the proportion of cells in G0/G1 phase (P < 0.05) (Fig. 7O, P). The results indicate that miR-9619-y arrests the cell cycle progression of goose embryonic myoblasts. This further suggests that miR-9619-y may influence the proliferative activity of myoblasts by regulating key cell cycle regulators. Fig. 7MiR-9619-y directly targets CCND1 and inhibits myoblast proliferation and differentiation. A Schematic diagram and prediction of the binding site of miR-9619-y in the CCND1 3’UTR. B Construction of the dual-luciferase reporter miR-9619-y- CCND1 3’UTR. The miR-9619-y binding site is highlighted in red. C Dual-luciferase reporter assays were performed after cotransfection of miR-9619-y mimics and WT or mutant vectors. The relative luciferase activity was presented as Renilla luciferase/ firefly luciferase. Data are means ± SD (n = 3). Different letters indicate significant differences (P<0.001). D The overexpression or interference efficiency of miR-9619-y. E, F, G, H EdU staining after transfection with the miR-9619-y mimics or inhibitors. Nuclei with Hoechst 33342 (blue) and S-phase myoblasts were stained with EdU (red) and counted with ImageJ. Quantification the ratio of EdU-positive cells/total cells after overexpression or interference of miR-9619-y. I, J, K, L MyH Cimmunofluorescence staining after transfection with the miR-9619-y mimics or inhibitors. Nuclei with DAPI (blue) and MyHC myotube (green). Quantification the ratio of of Myotube area/total area after overexpression or interference of miR-9619-y. M, N, O, P Cell cycle analysis of myoblasts aftertreatment with miR-9619-y mimics or inhibitors by flow cytometry and statistical analysis of the flow cytometry results RT-qPCR analysis revealed that during the proliferation stage, overexpression of miR-9619-y significantly down-regulated CCND1 mRNA expression (P < 0.001), while Myf5 and MyoD levels showed a non-significant decreasing trend (Fig. 8A). Conversely, inhibition of miR-9619-y significantly increased the mRNA levels of CCND1, Myf5, and MyoD (P < 0.05) (Fig. 8C). During the differentiation stage, overexpression of miR-9619-y significantly decreased the mRNA expression levels of CCND1 as well as differentiation marker genes Myh1 and MyoG (P < 0.001) (Fig. 8B). In contrast, interference with miR-9619-y significantly elevated the mRNA expression levels of CCND1, Myh1, and MyoG (P < 0.001) (Fig. 8D). Western blot analysis demonstrated that miR-9619-y bidirectionally regulated the expression of key proliferation and differentiation markers. Overexpression of miR-9619-y significantly down-regulated the protein levels of the proliferation marker MyoD and its target CCND1, while inhibition of miR-9619-y significantly up-regulated them (Fig. 8E, F, I, J). Similarly, regarding differentiation markers, miR-9619-y mimics significantly reduced the protein expression of MyHC and CCND1, whereas its inhibitors significantly increased their levels (Fig. 8G, H, K, L). All changes were statistically significant (P < 0.05). MiR-9619-y directly targets CCND1 and inhibits myoblast proliferation and differentiation. A Schematic diagram and prediction of the binding site of miR-9619-y in the CCND1 3’UTR. B Construction of the dual-luciferase reporter miR-9619-y- CCND1 3’UTR. The miR-9619-y binding site is highlighted in red. C Dual-luciferase reporter assays were performed after cotransfection of miR-9619-y mimics and WT or mutant vectors. The relative luciferase activity was presented as Renilla luciferase/ firefly luciferase. Data are means ± SD (n = 3). Different letters indicate significant differences (P<0.001). D The overexpression or interference efficiency of miR-9619-y. E, F, G, H EdU staining after transfection with the miR-9619-y mimics or inhibitors. Nuclei with Hoechst 33342 (blue) and S-phase myoblasts were stained with EdU (red) and counted with ImageJ. Quantification the ratio of EdU-positive cells/total cells after overexpression or interference of miR-9619-y. I, J, K, L MyH Cimmunofluorescence staining after transfection with the miR-9619-y mimics or inhibitors. Nuclei with DAPI (blue) and MyHC myotube (green). Quantification the ratio of of Myotube area/total area after overexpression or interference of miR-9619-y. M, N, O, P Cell cycle analysis of myoblasts aftertreatment with miR-9619-y mimics or inhibitors by flow cytometry and statistical analysis of the flow cytometry results Fig. 8Expression changes of proliferation- and differentiation-related markers regulated by miR-9619-y. A, B, C, D The mRNA expression of CCND1, Myf5, MyoD, Myh1 and MyoG were determined after overexpression or interference of miR-9619-y were measured by RT-qPCR. Panels A and C present data from the proliferation stage, while Panels B and D present data from the differentiation stage. E, F, G, H, I, J, K, L Protein expression of MyoD, MyHC and CCND1 after miR-9619-y mimics or inhibitors transfection were measured by Western blot, and grayscale analysis were performed by ImageJ Expression changes of proliferation- and differentiation-related markers regulated by miR-9619-y. A, B, C, D The mRNA expression of CCND1, Myf5, MyoD, Myh1 and MyoG were determined after overexpression or interference of miR-9619-y were measured by RT-qPCR. Panels A and C present data from the proliferation stage, while Panels B and D present data from the differentiation stage. E, F, G, H, I, J, K, L Protein expression of MyoD, MyHC and CCND1 after miR-9619-y mimics or inhibitors transfection were measured by Western blot, and grayscale analysis were performed by ImageJ Discussion As a pivotal epigenetic modification, DNA methylation maintains genomic stability and regulates gene expression. Its dynamic equilibrium is orchestrated by the antagonistic activities of DNA methyltransferases (DNMTs) and demethylases, specifically the TET family [22]. Seminal studies in murine models first demonstrated that the DNMT inhibitor 5-AZA induces the transdifferentiation of embryonic fibroblasts into myogenic cells, establishing a mechanistic link between DNA demethylation and myogenic fate determination [23]. Based on this foundation, the present study established a model to investigate the effects of 5-AZA and BC339 on DNA methylation levels in goose embryonic myoblasts. It is crucial to note that 5-AZA and BC339 exert effects beyond epigenetic modulation. As a nucleoside analog, 5-AZA incorporates into RNA, disrupting protein synthesis and inducing cytotoxicity independent of DNMT inhibition [24]. Consequently, while 5-AZA enhanced myogenesis concurrent with hypomethylation, we cannot rule out that off-target effects contributed to the observed phenotype. Future genetic studies are required to disentangle specific epigenetic mechanisms from these pharmacological artifacts. Furthermore, myogenic regulatory factors (MRFs), including MyoD and MyoG, are established core transcription factors governing skeletal muscle proliferation and differentiation, whose expression and activity are precisely modulated by the epigenetic landscape [25, 26]. Given the pivotal role of the epigenetic landscape in regulating MRFs and myogenesis, we investigated the expression of key regulatory enzymes—DNMTs and TETs—in geese exhibiting distinct body sizes. Our preliminary study identified significant differences in DNMT and TET expression in the developing leg muscles of Shitou and Wuzong goose embryos [10]. The expression levels of DNMT1 and DNMT3B were significantly higher in Shitou geese than in Wuzong geese (P < 0.05), while the opposite trend was observed for TET1, TET2, and TET3 [16]. The present study utilized an in vitro cell model to provide further functional evidence. Treatment with 5-AZA, which inhibits DNMT activity to induce global DNA demethylation, significantly enhanced the proliferation (EdU-positive rate) and differentiation (myotube fusion rate) of goose embryonic myoblasts. Conversely, treatment with BC339, which inhibits TET activity to promote DNA hypermethylation, markedly suppressed these processes. These complementary gain- and loss-of-function results are consistent with previous findings on the role of DNA methylation status in regulating muscle development [27] and provide, for the first time, direct functional evidence in goose embryonic myoblasts. The pro-proliferative and pro-differentiation effects observed herein are likely mediated by hypomethylation at the promoter regions of key myogenic factors, such as MyoD and MyoG. It has been established that transcriptional activation of these genes is often accompanied by demethylation of their regulatory elements [28]. Therefore, we hypothesize that 5-AZA treatment may create a global hypomethylation environment that specifically relieves transcriptional repression on certain pro-myogenic genes, thereby synergistically enhancing the myogenic program. In contrast, BC339 might impede this process by maintaining or reinforcing repressive methylation marks. The above hypotheses necessitate further experimental verification. To systematically elucidate the regulatory networks underlying these phenotypic changes, we performed whole-transcriptome sequencing on cells treated with 5-AZA and BC339. Although the ceRNA network integrates data across both stages, the expression of these regulatory RNAs is highly dynamic. Future studies should dissect whether specific axes within this network are restricted to the proliferation or differentiation phase, or if they function as universal regulators of myoblast fate. In cells treated with BC339 and 5-AZA, we identified the top five significantly differentially expressed genes, including KIF3A, CCND1, PPM1A, Table 2, and TGFBR1. Notably, all five genes have established functional links to the regulation of muscle development, supporting the biological relevance of our transcriptomic findings under altered DNA methylation states. The kinesin family member KIF3A is essential for intracellular transport and cilium formation, processes increasingly recognized for their role in organizing cytoskeletal dynamics and coordinating myoblast alignment prior to fusion [29]. CCND1 (Cyclin D1) is a well-characterized regulator of the G1/S phase transition, and its precise expression is crucial for driving the proliferation of myogenic precursor cells; Its down-regulation is a prerequisite for cell cycle exit and the initiation of terminal differentiation [30]. PPM1A acts as a negative regulator of the p38 MAPK pathway, a key signaling cascade that promotes myogenic differentiation. By dephosphorylating and inactivating p38, PPM1A can function as a brake on myogenesis, and its expression level is therefore critical for timing differentiation onset [31]. The genes Table 2 and TGFBR1 are central components of the TGF-β signaling pathway, a potent inhibitor of myogenic differentiation. The coordinated differential expression of this gene set-encompassing cell cycle control (CCND1), cytoskeletal organization (KIF3A), kinase signaling modulation (PPM1A), and a key inhibitory pathway (Table 2, TGFBR1)—strongly suggests that the DNA methylation modifiers 5-AZA and BC339 exert their effects on myoblast proliferation and differentiation by perturbing a coherent network of regulators that govern the balance between myogenic cell proliferation and differentiation [32–35]. This study identified the miR-9619-y–CCND1 axis as one experimentally validated regulatory module within the bioinformatically predicted ceRNA network. Functional assays confirmed that miR-9619-y directly targets the CCND1 3’UTR, thereby inhibiting proliferation and blocking the differentiation of goose embryonic myoblasts. These findings offer new insights into the regulatory mechanisms of non-coding RNAs in avian skeletal muscle development. While this axis provides direct evidence for miRNA-mediated regulation of CCND1, the remaining lncRNA/circRNA-miRNA-mRNA interactions in the network are computational predictions that require further experimental validation (e.g., RNA immunoprecipitation or competitive sponging assays) to confirm their biological relevance. Future studies should focus on validating additional axes within this network to fully elucidate its role in myogenesis. Additionally, a recognized limitation of this study is the lack of direct experimental evidence linking DNA methylation to every node within the constructed ceRNA network. Although pharmacological inhibition of DNMTs and TETs altered global methylation and gene expression profiles, we cannot conclusively rule out that the observed changes are indirect effects or secondary transcriptional responses. Direct locus-specific methylation validation for key candidates, particularly miR-9619-y and its predicted sponging lncRNAs/circRNAs, is required to confirm the “methylation-mediated” nature of this network. We acknowledge this gap and propose it as a key objective for our future research. As a key positive regulator of the G1-to-S phase transition, CCND1 forms complexes with CDK4/6 to phosphorylate Rb, releasing E2F transcription factors and driving cell cycle progression [36]. During skeletal myogenesis, CCND1 expression is tightly regulated to balance myoblast proliferation and differentiation. Our dual-luciferase reporter assays demonstrated direct binding of miR-9619-y to the CCND1 3’UTR, with mutation of the binding site reversing this effect, consistent with canonical miRNA–target interactions [30]. Notably, miR-9619-y overexpression significantly reduced EdU incorporation and arrested the cell cycle at the G0/G1 and G2/M phases while decreasing the S-phase population. This aligns with the established role of CCND1 in promoting G1 progression [30]. Conversely, miR-9619-y inhibition accelerated cell cycle entry and reduced the G0/G1 fraction, further confirming its anti-proliferation function via CCND1 down-regulation. In goose embryonic myoblasts transfected with miR-9619-y mimics, decreased expression levels of the proliferation-related genes MyoD and Myf5 were detected, which is consistent with previous findings that overexpression of miR-23a-5p reduces the expression of MyoD and Myf5 [37]. This further confirms that miR-9619-y inhibits the proliferation of goose embryonic myoblasts. Regarding myogenic differentiation, MyHC immunofluorescence staining confirmed that overexpression of miR-9619-y significantly inhibits myotube formation, which is consistent with previous reports that miRNAs affect myogenesis by regulating cell cycle-related genes. For example, miR-206 has been shown to reduce both CCND1 levels and proliferation rates, while inhibiting differentiation in C2C12 cells [38]. Additionally, following transfection with miR-9619-y mimics, the expression levels of differentiation-related genes Myh1 and MyoG in goose embryonic myoblasts were significantly down-regulated, which parallels the previously reported inhibitory effect of miR-103-3p on the expression of differentiation genes such as MyHC and MyoG [39]. As a result, miR-9619-y inhibits the differentiation of goose embryonic myoblasts. Based on the findings of this study, which demonstrate that miR-9619-y negatively regulates the development of goose skeletal muscle by inhibiting cell cycle-, proliferation-, and differentiation-related factors, future efforts to translate this discovery into livestock and poultry production could follow the pathways outlined below. These approaches are informed by successful translational cases within the field. For instance, miR-9619-y could serve as a molecular marker for assisted breeding to select for superior genetic lines. Specifically, by detecting the expression level or locus variation of miR-9619-y within goose breeding populations, individuals with low expression or functionally weakened alleles could be selected for breeding faster-growing muscle lines. Similarly, miR-34c-5p has been utilized as a molecular marker for broiler line improvement, with individuals exhibiting low expression showing significantly increased breast muscle weight [40]. Furthermore, a comprehensive, multi-trait balanced breeding strategy could be implemented. This would involve combining miR-9619-y with other miRNA markers that regulate intramuscular fat or meat quality (e.g., miR-128-3p) for coordinated multi-trait selection, thereby enhancing meat yield while preserving flavor [41]. Additionally, exploring gene editing and biotechnological applications holds promise. Technologies such as CRISPR/Cas9 could be employed to precisely edit the gene sequence or precursor of goose miR-9619-y, thereby creating gene-edited goose materials with improved muscle development traits. A successful precedent for this exists in the editing of the chicken AASS gene [40]. To provide more targets for such interventions, it is essential to further elucidate the complete regulatory network downstream of miR-9619-y. This includes determining whether it involves known signaling pathways such as PI3K/AKT, mTOR, or MAPK, and identifying its direct target genes [8, 42]. In summary, translating the foundational research on miR-9619-y into productive applications requires interdisciplinary collaboration between breeding, biotechnology, and other relevant fields. It is also crucial to closely monitor advances in the translational research of similar miRNAs, learning from their successful experiences while avoiding potential risks. Conclusion In this study, we computationally predicted a ceRNA network comprising 24 regulatory axes involving mRNAs, miRNAs, lncRNAs, and circRNAs, which governs goose embryonic myoblast development. Functional assays further demonstrated that miR-9619-y inhibits the proliferation and differentiation of goose embryonic myoblasts at transcriptional levels, by arresting cell cycle progression, targeting and suppressing CCND1, down-regulating myogenesis-related genes (MyoD, Myf5, Myh1, and MyoG), and reducing the expression of CCND1, MyoD, and MyHC proteins (Fig. 9). Collectively, these findings suggest that the predicted network represents a layer of post-transcriptional regulatory mechanisms underlying myogenesis in geese. Moreover, they provide candidate molecular targets for the genetic improvement of meat production traits in waterfowl breeding programs. Fig. 9Molecular regulatory mechanism of miR-9619-y. MiR-9619-y inhibits the proliferation and differentiation of goose embryonic myoblasts by targeting CCND1 and suppressing the expression of myogenic factors, including Myf5, MyoD, Myh1, and MyoG Molecular regulatory mechanism of miR-9619-y. MiR-9619-y inhibits the proliferation and differentiation of goose embryonic myoblasts by targeting CCND1 and suppressing the expression of myogenic factors, including Myf5, MyoD, Myh1, and MyoG Supplementary Information Supplementary Material 1. Figure S1. Effects of 5-AZA on DNA methylation in goose embryonic myoblasts. Figure S2. Effects of 5-AZA on the proliferation and differentiation of goose embryonic myoblasts. Figure S3. Effects of BC339 on DNA methylation in goose embryonic myoblasts. Figure S4. Effects of BC339 on the proliferation and differentiation of goose embryonic myoblasts. Figure S5. Sankey diagram of the top 10 mRNA, lncRNA, circRNA regulatory links with miRNA. Table S1. RNA-seq data quality control. Table S2. Summary of primer sequences. Table S3. Construction of related sequences of the pmiR-RB-Report™ 3'UTR reporter gene vector. Table S4. Differentially expressed mRNAs in leg muscle. Table S5. GO enrichment analysis of leg muscle. Table S6. KEGG pathway enrichment of leg muscle. Table S7. Differentially expressed lncRNAs in leg muscle. Table S8. Differentially expressed miRNAs in leg muscle. Table S9. Differentially expressed circRNAs in leg muscle. Supplementary Material 1. Figure S1. Effects of 5-AZA on DNA methylation in goose embryonic myoblasts. Figure S2. Effects of 5-AZA on the proliferation and differentiation of goose embryonic myoblasts. Figure S3. Effects of BC339 on DNA methylation in goose embryonic myoblasts. Figure S4. Effects of BC339 on the proliferation and differentiation of goose embryonic myoblasts. Figure S5. Sankey diagram of the top 10 mRNA, lncRNA, circRNA regulatory links with miRNA. Table S1. RNA-seq data quality control. Table S2. Summary of primer sequences. Table S3. Construction of related sequences of the pmiR-RB-Report™ 3'UTR reporter gene vector. Table S4. Differentially expressed mRNAs in leg muscle. Table S5. GO enrichment analysis of leg muscle. Table S6. KEGG pathway enrichment of leg muscle. Table S7. Differentially expressed lncRNAs in leg muscle. Table S8. Differentially expressed miRNAs in leg muscle. Table S9. Differentially expressed circRNAs in leg muscle. Supplementary Material 2. Supplementary Material 2.